Resmed (RMD) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $1.2 billion.
- Resmed's Total Current Liabilities rose 4649.91% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 4649.91%. This contributed to the annual value of $1.0 billion for FY2025, which is 1191.07% up from last year.
- Latest data reveals that Resmed reported Total Current Liabilities of $1.2 billion as of Q4 2025, which was up 4649.91% from $1.3 billion recorded in Q3 2025.
- Resmed's 5-year Total Current Liabilities high stood at $1.3 billion for Q3 2025, and its period low was $621.1 million during Q4 2021.
- Over the past 5 years, Resmed's median Total Current Liabilities value was $771.9 million (recorded in 2023), while the average stood at $838.7 million.
- As far as peak fluctuations go, Resmed's Total Current Liabilities soared by 5893.21% in 2021, and later tumbled by 2439.96% in 2022.
- Resmed's Total Current Liabilities (Quarter) stood at $621.1 million in 2021, then increased by 17.98% to $732.7 million in 2022, then grew by 4.28% to $764.1 million in 2023, then increased by 11.5% to $852.0 million in 2024, then skyrocketed by 46.5% to $1.2 billion in 2025.
- Its Total Current Liabilities stands at $1.2 billion for Q4 2025, versus $1.3 billion for Q3 2025 and $1.0 billion for Q2 2025.